ATE247970T1 - Tierärztliche zusammensetzungen zur behandlung von parasiterkrankungen - Google Patents

Tierärztliche zusammensetzungen zur behandlung von parasiterkrankungen

Info

Publication number
ATE247970T1
ATE247970T1 AT01907553T AT01907553T ATE247970T1 AT E247970 T1 ATE247970 T1 AT E247970T1 AT 01907553 T AT01907553 T AT 01907553T AT 01907553 T AT01907553 T AT 01907553T AT E247970 T1 ATE247970 T1 AT E247970T1
Authority
AT
Austria
Prior art keywords
treatment
compositions
rafoxanide
parasitic diseases
solvents
Prior art date
Application number
AT01907553T
Other languages
English (en)
Inventor
A Abdul Rahman Shoa
Original Assignee
New Pharma Res Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Pharma Res Sweden Ab filed Critical New Pharma Res Sweden Ab
Application granted granted Critical
Publication of ATE247970T1 publication Critical patent/ATE247970T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/609—Amides, e.g. salicylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01907553T 2000-02-29 2001-02-22 Tierärztliche zusammensetzungen zur behandlung von parasiterkrankungen ATE247970T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00104126A EP1129713A1 (de) 2000-02-29 2000-02-29 Tierärztliche Zusammensetzungen zur Behandlung von Parasiterkrankungen
PCT/EP2001/002037 WO2001064222A1 (en) 2000-02-29 2001-02-22 Veterinary compositions for the treatment of parasitic diseases

Publications (1)

Publication Number Publication Date
ATE247970T1 true ATE247970T1 (de) 2003-09-15

Family

ID=8167975

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01907553T ATE247970T1 (de) 2000-02-29 2001-02-22 Tierärztliche zusammensetzungen zur behandlung von parasiterkrankungen

Country Status (11)

Country Link
US (2) US6777448B2 (de)
EP (2) EP1129713A1 (de)
CN (1) CN1213756C (de)
AT (1) ATE247970T1 (de)
AU (2) AU2001235489B2 (de)
BR (1) BR0108727A (de)
DE (1) DE60100666T2 (de)
ES (1) ES2206406T3 (de)
NZ (1) NZ521533A (de)
TR (1) TR200302027T4 (de)
WO (1) WO2001064222A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
KR20050103685A (ko) * 2004-04-27 2005-11-01 삼성전자주식회사 액정 표시 장치용 휘도 강화 필름 및 그 제조 방법
GB0711957D0 (en) * 2007-06-21 2007-08-01 Syntopix Ltd Formulations
DE102010051404B4 (de) 2010-11-16 2017-08-31 Marc de Cocq Verwendung von substituierten Salicylaniliden zur Behandlung von Fischen
RU2569740C1 (ru) * 2014-05-20 2015-11-27 Рамзия Тимергалеевна Маннапова Способ коррекции минерального обмена при диктиокаулезе овец
CN104800158A (zh) * 2015-04-14 2015-07-29 四川美嘉龙生物科技有限公司 一种碘醚柳胺制剂及制备方法
AR116524A1 (es) * 2018-10-04 2021-05-19 Elanco Tiergesundheit Ag Potenciación de tratamiento de helmintos
EP4149436A4 (de) 2020-05-15 2025-01-08 Rutgers, the State University of New Jersey Zusammensetzungen und verfahren zur behandlung von wunden
CN117205181A (zh) * 2023-10-23 2023-12-12 青岛康地恩动物药业有限公司 一种鹅脱氧胆酸-碘醚柳胺脂质纳米粒制剂的制备方法
CN118986876A (zh) * 2024-08-09 2024-11-22 山东德州神牛药业有限公司 一种碘醚柳胺纳米混悬液及其制备方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL184257C (nl) 1974-06-19 1989-06-01 Merck & Co Inc Werkwijze voor het bereiden van rafoxanide preparaten.
US4128632A (en) * 1978-02-13 1978-12-05 Merck & Co., Inc. Solubilization of Rafoxanide
AU527154B2 (en) * 1978-12-15 1983-02-17 Pitman-Moore Australia Limited Composition and process
ZA842571B (en) * 1983-04-07 1985-11-27 Merck & Co Inc Novel synergistic antiparasitic combinations
IE58016B1 (en) * 1983-08-12 1993-06-16 Ici Australia Ltd Pour-on formulation for the control of parasites
NZ209100A (en) * 1983-08-22 1987-01-23 Ici Australia Ltd Topical compositions for control of endoparasites
AU5733986A (en) * 1985-05-13 1986-11-20 Syntex (U.S.A.) Inc. Anthelmintic compositions comprising a benzimidazole derivative and the fasciolicide rafoxanide
US5340804A (en) * 1991-11-14 1994-08-23 Eli Lilly And Company 1,5-diphenyl-3-formazancarbonitril parasiticides
WO1995016447A1 (en) * 1993-12-13 1995-06-22 Michael Hilary Burke Anthelmintic composition containing rafoxanide and fenbendazole
EP1137627A1 (de) 1998-12-10 2001-10-04 Bayer Aktiengesellschaft Verfahren zur herstellung von zwischenprodukten für die strobilurin synthese

Also Published As

Publication number Publication date
ES2206406T3 (es) 2004-05-16
US20040072909A1 (en) 2004-04-15
NZ521533A (en) 2003-03-28
CN1213756C (zh) 2005-08-10
EP1129713A1 (de) 2001-09-05
BR0108727A (pt) 2002-11-05
CN1406130A (zh) 2003-03-26
US6777448B2 (en) 2004-08-17
DE60100666T2 (de) 2004-06-24
EP1259244B1 (de) 2003-08-27
DE60100666D1 (de) 2003-10-02
US20030049309A1 (en) 2003-03-13
AU3548901A (en) 2001-09-12
AU2001235489B2 (en) 2004-11-18
WO2001064222A1 (en) 2001-09-07
EP1259244A1 (de) 2002-11-27
TR200302027T4 (tr) 2004-01-21

Similar Documents

Publication Publication Date Title
ATE355075T1 (de) Behandlung der glykogenspeicherkrankheit typ ii
UY27320A1 (es) Nuevas composiciones farmacéuticas
DK1133316T3 (da) Adenovirus-formulering til genterapi
DK1345611T3 (da) Antibiotisk/analgetisk formulering og en fremgangsmåde til fremstilling deraf
ATE409458T1 (de) Flüssige darreichungsformen zur prävention und zur behandlung von schleimhautaffektionen
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
ATE523209T1 (de) Flüssige formulierung von fsh
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
DE69418468D1 (de) Viskoelastische zusammensetzungen aus organischen fluorierten verbindungen
EA200400689A1 (ru) Фармацевтические и косметические композиции, содержащие ароматические альдегиды, содержащие оксигруппу
BRPI0418115A (pt) formulação lìquida estável de hormÈnio de crescimento
DE60100666D1 (de) Tierärztliche zusammensetzungen zur behandlung von parasiterkrankungen
BRPI0415906A (pt) formulão inseticida
EE200200636A (et) Dibensoasuleeni derivaadid, nende valmistamismeetodid ja kasutamine
ATE440838T1 (de) Pharmazeutisch aktive sulfonylaminosäurederivate
NO20042459L (no) Vannbasert farmasoytiske formuleringer av vannloselige prodrug av propofol
AR039388A1 (es) Formulaciones liquidas de baja dosis de entecavir y uso
ES2315942T3 (es) Composicion veterinaria inyectable que contiene florfenicol.
EA200701986A1 (ru) Улучшенные составы фенофибрата, содержащие ментол или смесь пэг/полоксамера
MEP18508A (en) Pharmaceutical composition and preparation thereof
PL1663186T3 (pl) Stabilna kompozycja farmaceutyczna związku fluoroeterowego do stosowania w znieczuleniu, sposób stabilizowania związku fluoroeterowego, zastosowanie środka stabilizującego do zapobiegania degradacji związku fluoroeterowego
KR20080011224A (ko) 외부 기생충 억제용 겔 조성물
NO20081754L (no) Anthelmintiske formuleringer
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
AR034835A1 (es) Composicion micelar para el tratamiento de enfermedades parasitarias en animales y uso de dicha composicion.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties